Maurice Wilde

528 total citations
15 papers, 410 citations indexed

About

Maurice Wilde is a scholar working on Toxicology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Maurice Wilde has authored 15 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Toxicology, 5 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Maurice Wilde's work include Forensic Toxicology and Drug Analysis (12 papers), Cannabis and Cannabinoid Research (5 papers) and Poisoning and overdose treatments (3 papers). Maurice Wilde is often cited by papers focused on Forensic Toxicology and Drug Analysis (12 papers), Cannabis and Cannabinoid Research (5 papers) and Poisoning and overdose treatments (3 papers). Maurice Wilde collaborates with scholars based in Germany, Switzerland and Italy. Maurice Wilde's co-authors include Volker Auwärter, Roberta Pacifici, Adriano Tagliabracci, Simona Pichini, Francesco Paolo Busardò, Renata Solimini, Florian Franz, Maren Hermanns‐Clausen, Lukas Mogler and Merja A. Neukamm and has published in prestigious journals such as Frontiers in Pharmacology, Toxicology Letters and Forensic Science International.

In The Last Decade

Maurice Wilde

15 papers receiving 395 citations

Peers

Maurice Wilde
Timothy P. Rohrig United States
Matthew McMullin United States
Meejung Park South Korea
T. Ishida Japan
Maurice Wilde
Citations per year, relative to Maurice Wilde Maurice Wilde (= 1×) peers Magdalene H.Y. Tang

Countries citing papers authored by Maurice Wilde

Since Specialization
Citations

This map shows the geographic impact of Maurice Wilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice Wilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice Wilde more than expected).

Fields of papers citing papers by Maurice Wilde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice Wilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice Wilde. The network helps show where Maurice Wilde may publish in the future.

Co-authorship network of co-authors of Maurice Wilde

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice Wilde. A scholar is included among the top collaborators of Maurice Wilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice Wilde. Maurice Wilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Giorgetti, Arianna, et al.. (2021). A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues. Forensic Toxicology. 40(1). 180–188. 7 indexed citations
3.
Grafinger, Katharina Elisabeth, et al.. (2021). Pharmacological and metabolic characterization of the novel synthetic opioid brorphine and its detection in routine casework. Forensic Science International. 327. 110989–110989. 12 indexed citations
4.
Wilde, Maurice, Volker Auwärter, & Bjoern Moosmann. (2021). New psychoactive substances—Designer benzodiazepines. 3(6). 10 indexed citations
5.
Halter, Sebastian, Maurice Wilde, Folker Westphal, et al.. (2020). Cumyl‐CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain. Drug Testing and Analysis. 13(1). 208–216. 21 indexed citations
6.
Müller, Dieter, Hartmud Neurath, Merja A. Neukamm, et al.. (2019). New synthetic opioid cyclopropylfentanyl together with other novel synthetic opioids in respiratory insufficient comatose patients detected by toxicological analysis. Clinical Toxicology. 57(9). 806–812. 17 indexed citations
7.
Wilde, Maurice, et al.. (2019). Acute severe intoxication with cyclopropylfentanyl, a novel synthetic opioid. Toxicology Letters. 320. 109–112. 18 indexed citations
8.
Wilde, Maurice, Simona Pichini, Roberta Pacifici, et al.. (2019). Metabolic Pathways and Potencies of New Fentanyl Analogs. Frontiers in Pharmacology. 10. 238–238. 114 indexed citations
10.
Mogler, Lukas, Sebastian Halter, Maurice Wilde, Florian Franz, & Volker Auwärter. (2018). Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE. Forensic Toxicology. 37(1). 154–163. 21 indexed citations
11.
Auwärter, Volker, et al.. (2018). Mixed intoxication by the synthetic opioid U‐47700 and the benzodiazepine flubromazepam with lethal outcome: Pharmacokinetic data. Drug Testing and Analysis. 10(8). 1336–1341. 39 indexed citations
12.
Mogler, Lukas, et al.. (2018). Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL‐PEGACLONE and detection in human urine samples. Drug Testing and Analysis. 10(5). 886–891. 28 indexed citations
13.
Moosmann, Bjoern, Philippe Bisel, Folker Westphal, et al.. (2018). Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'‐chlorodiazepam (Ro5–4864). Drug Testing and Analysis. 11(3). 541–549. 14 indexed citations
14.
Mogler, Lukas, Florian Franz, Maurice Wilde, et al.. (2018). Phase I metabolism of the carbazole‐derived synthetic cannabinoids EG‐018, EG‐2201, and MDMB‐CHMCZCA and detection in human urine samples. Drug Testing and Analysis. 10(9). 1417–1429. 15 indexed citations
15.
Jantscheff, Peter, T Ross, Martin Schlesinger, et al.. (2015). Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases. Lipids in Health and Disease. 14(1). 69–69. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026